Low phylloquinone (vitamin K 1 ) intakes have been associated with low bone mineral density in older adults. Phylloquinone intakes and serum undercarboxylated osteocalcin (ucOC) levels were assessed in ninety-seven apparently healthy, free-living Irish women aged 50 -75 years. Phylloquinone intakes were estimated using a detailed dietary history, which measured habitual food intakes from a typical 14 d period, and recently published food composition data for phylloquinone. Fasting serum ucOC was measured using an enzyme immunoassay. The median daily intake of phylloquinone in the group from all sources was 108·8 mg and from food sources only was 106·6 mg, indicating that approximately 99 % of the phylloquinone came from food. Vegetables and vegetable dishes contributed 67 % of the total phylloquinone intake, but further analysis showed that broccoli, cabbage and lettuce were the primary sources, making a total contribution of 44 %. Twenty per cent of the women had a phylloquinone intake below the UK recommendation of 1 mg/kg body weight per day and 34 % failed to meet the US Adequate Intake value of 90 mg/day. Mean serum ucOC levels in the women were 6·2 (SD 1·7) ng/ml and were predicted by phylloquinone intake (b 22·20, generated from log-transformed phylloquinone intake data; P¼0·04). On the basis of comparisons with both UK recommendations and US Adequate Intakes for phylloquinone, the habitual intakes of phylloquinone in a high proportion of Irish postmenopausal women may not be adequate.
The function of vitamin K is to serve as a co-factor for vitamin K-dependent carboxylase, a microsomal enzyme that facilitates the post-translational conversion of glutamyl to g-carboxyglutamyl residues (Esmon et al. 1975) . Its classic role in this respect involves the synthesis of several coagulation factors, including plasma procoagulants, prothrombin (factor II), factors VII, IX and X, and anticoagulants (proteins C and S) (Price, 1988; Shearer, 1990 Shearer, , 2000 Institute of Medicine, 2001 ). The maintenance of plasma prothrombin concentration was the basis for the recommended dietary intake value of 1 mg phylloquinone (vitamin K 1 ) per kilogram body weight per day, set by the National Research Council (1989) in the USA and by the Department of Health (1991) in the UK. More recently, the identification of g-carboxyglutamyl residue-containing proteins in bone, notably osteocalcin and matrix carboxyglutamyl residue-protein, has generated much interest in the role of vitamin K in bone metabolism and bone health (Binkley & Suttie, 1995; Vermeer et al. 1995; Institute of Medicine, 2001; Weber, 2001) .
The findings of two large prospective cohort studies (the Nurses' Health Study and the Framingham Heart Study) suggest an association between the relative risk of hip fracture and phylloquinone intake (Feskanich et al. 1999; Booth et al. 2000) . Furthermore, low dietary phylloquinone intakes have recently been associated with low bone mineral density (BMD) in elderly subjects (Booth et al. 2003) . The serum concentration of undercarboxylated osteocalcin (ucOC) is a sensitive indicator of vitamin K status, as high serum levels of ucOC are indicative of low vitamin K status and vice versa Sokoll et al. 1997) . In addition, the circulating concentration of ucOC has been reported to be a predictor of low BMD (Szulc et al. 1994; Jie et al. 1996) and hip fracture risk (Szulc et al. 1993 (Szulc et al. , 1996 Vergnaud et al. 1997) .
Recent evidence has suggested that phylloquinone intakes that are sufficient to maintain normal blood coagulation may be suboptimal for bone health Vermeer et al. 1996; Sokoll et al. 1997) . Furthermore, besides its role in bone health, there is also a growing interest in the possible role of vitamin K in atherosclerosis Shearer, 2000; Institute of Medicine, 2001) and cognitive function (Rambeck & Stahelin, 2001) .
In this context, the US Food and Nutrition Board has recently upwardly revised its recommendation for the daily dietary intake of phylloquinone, and has established an Adequate Intake of 90 and 120 mg/d for adult females and males, respectively (Institute of Medicine, 2001 ). This Adequate Intake was based on estimating the amount of phylloquinone habitually consumed by a group of healthy people and on the assumption that these amounts were adequate to promote all aspects of health (Institute of Medicine, 2001) .
There are limited data on the dietary intake of phylloquinone in European populations. Available data suggest that the mean intake of phylloquinone is about 60 -80 mg/d in countries such as Scotland, the UK and Norway (Price et al. 1996; Askim, 2001; Thane et al. 2002) and about 250 mg/d in the Netherlands (Schurgers et al. 1999) . Using a 7 d food diary, we recently estimated the phylloquinone intake in a representative sample of Irish adults, aged 18 -64 years, to be 79 mg/d (Duggan et al. 2004) ; of this population, only 17 % of men and 27 % of women met the US Adequate Intake. Some studies have reported a decrease in phylloquinone intake with age, especially in adults over the age of 65 years (Schurgers et al. 1999; Thane et al. 2002) . There are currently no data on biochemical vitamin K status, using indices such as serum ucOC, for healthy Irish adults. As postmenopausal women are at increased risk of osteoporosis, and as Duggan et al. (2004) showed that Irish women have a lower intake of phylloquinone than Irish men, it is possible that older women may be a group at increased risk of suboptimal phylloquinone intake and status. Therefore, the objectives of the present study were to estimate the habitual intakes and adequacy of intakes of phylloquinone and to measure circulating ucOC levels in a group of Irish postmenopausal women.
Subjects and methods

Subjects
A convenience sample of ninety-seven apparently healthy, free-living postmenopausal women (mean age 65·0 (range 50 -75) years) was recruited by leaflet or direct contact from the Cork region. None of the subjects was suffering from any condition or taking any medications likely to affect vitamin K status.
Ethical considerations
Ethical approval for the study was granted by the Clinical Research Ethics Committee of the Cork Teaching Hospitals. Before participation in this study, all subjects signed an informed consent document.
Study design
This was an observational study of phylloquinone intake and status in Irish postmenopausal women. Each participant was invited to provide a fasting blood sample at the University during February -March 2002 , August-September 2002 or February -March 2003 . After an overnight fast, a blood sample (20 ml) was taken between 08.30 and 10.30 hours from each participant (see later). Anthropometric measurements (weight and height) were taken using a Seca Alpha 770 digital scale (CMS Weighing Equipment Ltd, London, UK) and a Leicester height measure (CMS Weighing Equipment Ltd), respectively. Habitual food intake was assessed by a 14 d dietary history, which consisted of a one-to-one interview detailing usual food and drink intake over a typical 14 d period. A general health and lifestyle questionnaire was administered to each participant, which provided information on medical history, the use of hormone replacement therapy, visits to hospital, fracture history and smoking history. The questionnaire also detailed the use of nutritional supplements, including vitamin K-containing supplements. Tapsell et al. (2000) have described the detailed methodology of the dietary history that was used to collect food and beverage intake data. In brief, the interviewer began by asking about the first meal of the day (usually breakfast) and continued in a sequential order until the last meal of the day was recorded. The dietary history collected a detailed description of the food and/or drink consumed, the brand name (if applicable) and the quantity of the food and/or drink consumed over a typical 14 d period. Food intakes were quantified using a photographic food atlas of food portion sizes (Ministry of Agriculture, Fisheries and Food, 1997), manufacturer's data and standard portion sizes (Ministry of Agriculture, Fisheries and Food, 1997). Information was collected on the time and location of each eating or drinking occasion, and participants were asked about their current use of nutritional supplements. A short food questionnaire was attached to the end of the dietary history to use as a cross-check.
Dietary assessment methodology
Food intake data were analysed using WISP (Tinuviel Software, Warrington, UK), which incorporated data from the fifth edition of McCance and Widdowson's The Composition of Foods (Holland et al. 1995) and supplemental volumes. Our research group had previously expanded the fifth edition to include about 1000 new food codes, including recipes, nutritional supplements and new products (Harrington et al. 2001) . In addition, the phylloquinone composition database compiled by Bolton-Smith et al. (2000) had been added to the food composition database (Duggan et al. 2004 ). In the current study, additional recipes provided by the ninetyseven subjects were analysed for their phylloquinone content and were also included in the database. Food and nutrient intake data were exported from WISP and analysed in SPSS for Windows version 11.0 (SPSS Inc., Chicago, IL, USA).
Assessment of adequacy of phylloquinone intake
As there is currently insufficient evidence to establish an average requirement for phylloquinone, it was not possible to use the cut-point method of Carriquiry (1999) to estimate the prevalence of inadequate dietary intakes in the sample. However, in the absence of an average requirement, the US Food and Nutrition Board has recently established Adequate Intakes of 90 and 120 mg/d for adult women and men, respectively (Institute of Medicine, 2001), based on reported intakes in apparently healthy US population groups. In the UK, the recommended intake for phylloquinone is 1 mg/kg body weight per day (Department of Health, 1991), based on its role in blood clotting. Therefore, to gain some measure of the adequacy of phylloquinone intake, the proportions of postmenopausal women in the present study not meeting the UK recommendation and not consuming the US Adequate Intake were calculated.
Collection and preparation of blood samples
Blood was collected by venepuncture into a Vacutainer tube (BD Vacutainer Systems, Plymouth, UK) with no additive and processed to serum, using a refrigerated centrifuge, then immediately stored at 2 808C until required for analysis.
Serum undercarboxylated osteocalcin
Serum ucOC levels were measured in serum samples using a recently developed ELISA (Undercarboxylated (Glu-OC) EIA kits; Takara Biomedical Group, Otsu, Shia, Japan). The intraand interassay CV were 4·4 and 7·5 %, respectively.
Statistical analysis
Data for all variables, with the exception of estimates of phylloquinone intake, were normally distributed, as assessed using Kolmogorov-Smirnov tests (P. 0·1). Data estimating phylloquinone intake appeared to have a slight, borderline significant (P¼0·08) positive skew, but the data approached a nearnormal distribution (P.0·1) after log-transformation, and these transformed intake data were used for all statistical analyses. Data are presented as means and standard deviations, as well as medians and 5th and 95th percentiles. Differences in phylloquinone intake and serum ucOC level between women aged 64 years or less and over 64 years were evaluated using unpaired Student's t tests. Stepwise linear regression analysis was used to investigate the association between phylloquinone intake and serum ucOC level, controlling for age, BMI and energy intake.
Results
The mean age, height, weight and BMI of the women are shown in Table 1 . Sixty-seven percent of women were regular users of nutritional supplements, but only 26 % of these supplements contained phylloquinone. Intakes of phylloquinone (as mg and mg/10 MJ food energy) are shown in Table 2 . The median daily intake of phylloquinone from all sources was 108·8 mg, and from food sources only was 106·6 mg, showing that approximately 99 % of the phylloquinone intake came from food.
When the women were split into two groups of those aged over 64 years (n 42) and those aged 64 years or less (n 55), there was no significant difference in phylloquinone intake between them (Table 3) . Of the ninety-seven women who participated in the study, 20 % had a phylloquinone intake below the UK recommendation of 1 mg/kg body weight per day (Department of Health, 1991) . Comparing the current phylloquinone intake data with the current US recommendations for adult women (Institute of Medicine, 2001) , 34 % of all women failed to meet the Adequate Intake of 90 mg/d. Forty per cent of the women aged 65-75 years and 26 % of those aged 50-64 years did not achieve the US Adequate Intake, whereas 25 % of the 65 -75-year-olds and 14 % of the 50 -64-year-olds failed to achieve the UK recommendation.
On the basis of their contribution to phylloquinone intake, foods were aggregated to eight large food groups that provided 91 % of the total intake (Fig. 1) . Overall, vegetables and vegetable dishes contributed 67 % of the total phylloquinone intake. Fats and oils, fruit, and milk and milk products also made minor contributions of 7·6, 4·6 and 4·1 %, respectively. As the vegetable food group provided 67 % of the phylloquinone intake, this group was disaggregated into nine vegetable food groupings to identify the actual sources of phylloquinone intake (Fig. 2) . Vegetables provided about 50 % to the total phylloquinone intake; of this, broccoli was the highest single source, providing 22 % of total intake, followed by cabbage (12 %) and lettuce (10 %).
Mean serum ucOC concentration in the group was 6·2 (SD 1·7) ng/ml. There was no significant difference in serum ucOC between women aged over 64 (n 41) and 64 or under (n 55). Serum ucOC levels were significantly inversely related to phylloquinone intakes (Fig. 3) . Stepwise linear regression analysis controlling for BMI and energy intake showed that vitamin K intake (b 20·006; P¼0·03) and age (b 20·04; P¼0·05) were significant predictors of serum ucOC value (n 96).
Discussion
The current report describes the first assessment of phylloquinone intake using a 14 d dietary history, and vitamin K status using serum ucOC concentrations, in ninety-seven Irish women aged between 50 and 75 years. The mean phylloquinone intake in postmenopausal women in the present study was higher (123·5 mg/d) than that previously reported by our group for Irish postmenopausal women aged 50 -64 years (82 mg/d; Duggan et al. 2004 ). There are two probable explanations for the differences observed. First, although the food composition data were identical, the method by which vitamin K intake was assessed in the two studies differed; we used a 14 d dietary history in the present study, whereas Duggan et al. (2004) reported data from a 7 d food diary. Second, Duggan et al. (2004) reported data from a nationally representative sample of women aged 50-64 years, whereas the current sample was self-selected and consisted of highly motivated individuals with an interest in diet and bone health. Lahmann & Kumanyika (1999) found that a high awareness of health and nutrition favourably affected dietary quality in older women. It should be noted that subjects in the current study, although aware that their overall diet was being assessed as part of a diet and bone health study, were not aware we were focusing on vitamin K in particular.
The current phylloquinone intake data were also higher than the value reported by Thane et al. (2002) in UK women of the same age (66 mg/d; n 325), surveyed during the National Diet and Nutrition Survey of people aged 65 years and over (Finch et al. 1998) . However, Yan et al. (2004) recently reported that British elderly men and women (aged 60-83 years, mean 68 years; n 134) recruited from general practice surgeries in Cambridge had a mean phylloquinone intake of 117 mg/d. These studies, in addition to our current and previous (Duggan et al. 2004 ) data, illustrate the importance of considering the impact of sampling method on estimates of dietary intake.
In the US, Booth et al. (1995) reported a mean phylloquinone intake of 89 mg/d for 362 postmenopausal women. McKeown et al. (2002) reported that mean daily phylloquinone intakes were around 132-135 mg/d for adults (aged 50 years and older) participating in the Framingham Offspring Cohort study. In the Netherlands, Schurgers et al. (1999) reported mean daily phylloquinone intakes of about 250 mg/d for adults aged 65 years and older, whereas Jie et al. (1995) reported that Dutch postmenopausal women (mean age 66 years; n 113) had a mean daily phylloquinone intake of approximately 227 mg/d. The estimates of intake from these latter four studies were obtained using food-frequency questionnaires, which tend to estimate higher intakes than food-diary methods (Herbert et al. 1998; French et al. 2001) .
Phylloquinone is ubiquitously distributed in the diet; however, the range of concentrations in different food groups is very wide . The main dietary sources of phylloquinone in the present study are comparable to those reported for studies in the UK (Price et al. 1996; Fenton et al. 1997; Thane et al. 2002; Yan et al. 2004 ) and the only other study of Irish adults (Duggan et al. 2004) . Foods in the Irish diet that have high concentrations of phylloquinone are green vegetables, such as parsley, spinach and cabbage (400-3000 mg/100 g), whereas broccoli, lettuce, coleslaw and vegetable oils have intermediate levels (100 -200 mg/ 100 g). Of these, broccoli, cabbage and lettuce were the most important providers of phylloquinone in the current study (44 % between them), as they were consumed in the highest quantities. These data were similar to those from the recent report by Yan et al. (2004) , in which green leafy vegetables contributed 50·4 % to mean daily intake of phylloquinone in UK adults aged 60-83 years. In the same report by Yan et al. (2004) , elderly Chinese adults, who consumed comparatively more green vegetables than their UK counterparts (127 v. 39 g/d) obtained 68·5 % of their phylloquinone intake from green vegetables, and they had better vitamin K status. In studies using nationally representative samples in Ireland and the UK, green vegetables made a lower contribution to phylloquinone intake. For example, Duggan et al. (2004) reported that green vegetables contributed only 26 % to phylloquinone intake in Irish adults aged 50-64 years, and et al. (2002) showed that only 28 % phylloquinone intake in elderly UK adults came from green vegetables. Some studies have reported a decrease in phylloquinone intake with age, especially in adults over the age of 65 years, and more notably over the age of 85 years (Schurgers et al. 1999; Thane et al. 2002) . In the present study, there was no significant difference in phylloquinone intake between women aged 50 -64 years and those aged 65-75 years, but the percentage achieving recommended target intakes was lower in the older women. Contrary to studies that report a decrease in phylloquinone intake with age, Duggan et al. (2004) reported that younger Irish adults (aged 18 -35 years) had a lower mean phylloquinone intake than older adults (aged 36-64 years). This was probably due to the lower vegetable consumption of younger Irish adults compared with over-35-year-olds, as previously reported by O'Brien et al. (2003) .
In the present study, over half of the women aged 65 -75 years and almost a quarter of those aged 50 -64 years were not consuming the US recommended intake levels. In addition, a quarter of the 65-75-year-olds and 14 % of the 50-64-year-olds failed to achieve the UK recommendation. Furthermore, although the mean daily phylloquinone intakes of the women in the present study were similar to or slightly higher than those reported for American and European intakes, there is evidence to suggest that these levels may be insufficient for the maintenance of bone health. In the Nurses' Health Study, phylloquinone intakes of less than 109 mg/d were associated with an increased risk of hip fracture (Feskanich et al. 1999) . In the Framingham Heart Study, elderly men and women in the highest quartile of phylloquinone intake (median 254 mg/d) had a significantly lower adjusted relative risk of hip fracture than did those in the lowest quartile of intake (median 56 mg/d; Booth et al. 2000) . Furthermore, low dietary phylloquinone intakes have recently been associated with low BMD (Booth et al. 2003) . Women in the lowest quartile of phylloquinone intake (70 mg/d) had significantly lower (P , 0·005) mean BMD at the femoral neck and spine than did those in the highest quartile of phylloquinone intake (309 mg/d; Booth et al. 2003) .
In the present study, ucOC level was inversely associated with phylloquinone intake. This is in agreement with findings in UK-based elderly subjects (Yan et al. 2004) . Besides acting as a marker of vitamin K nutriture (Sokoll & Sadowski, 1996) , serum ucOC has been reported to be an indicator of risk of hip fracture (Szulc et al. 1993; Vergnaud et al. 1997; Booth et al. 2000) and a predictor of BMD (Szulc et al. 1994 ; see reviews by Institute of Medicine, 2001; Weber, 2001 ). The mean serum ucOC for postmenopausal women in the present study (6·0 ng/ml) was higher than that of a group of Danish postmenopausal women (3·8 ng/ml; mean age 62 years; n 31), which used the same assay (S. Bugel, unpublished results). Furthermore, dietary supplementation of the Danish postmenopausal women with 200 and 500 mg phylloquinone led to a 40 % and 68 % reduction, respectively, in serum ucOC level after 6 weeks (S. Bugel, personal communication). Therefore, the current data suggest that subclinical vitamin K deficiency may have been present in some of the postmenopausal women, in agreement with the findings of others Fig. 3 . Relationship between phylloquinone intake (log-transformed) and serum undercaboxylated osteocalcin (ucOC) level in 50-75-year-old Irish women (n 96). r ¼ 2 0·288, P ¼ 0·004. (Knapen et al. 1989; Plantalech et al. 1990; Binkley et al. 2000) .
In relation to future work in the area of vitamin K status in postmenopausal women, it is worth emphasising that the direct assays for measuring ucOC (as used in the present study) appear to overestimate values compared with indirect bindings assays, which express ucOC as a percentage of total osteocalcin (Gundberg et al. 1998) . Notwithstanding this, however, Conway et al. (2005) recently pointed to evidence from studies among elderly subjects which showed that the fractional decreases in the percentage of ucOC brought about with vitamin K supplementation were very similar whether measured with direct assays for ucOC (as in the present study) or with indirect bindings assays.
In conclusion, habitual intakes of phylloquinone in a high proportion of relatively well-nourished Irish postmenopausal women may not be adequate to maintain bone health, on the basis of comparisons with both the 1991 UK recommendations and the 2001 US Adequate Intake for phylloquinone. Further research on the impact of vitamin K status on postmenopausal bone health is needed. In addition, investigations of phylloquinone intake in other age groups within the Irish population, particularly younger age groups, are warranted.
